Tyvense 70 mg Capsules, Hard Ireland - English - HPRA (Health Products Regulatory Authority)

tyvense 70 mg capsules, hard

takeda pharmaceuticals international ag ireland branch - lisdexamfetamine dimesylate - capsule, hard - psychoanaleptics

XYNTHA  500 IU Israel - English - Ministry of Health

xyntha 500 iu

pfizer pharmaceuticals israel ltd - moroctocog alfa - lyophylized powder and solvent for solution for injection - moroctocog alfa 500 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency)

XYNTHA 1000 IU Israel - English - Ministry of Health

xyntha 1000 iu

pfizer pharmaceuticals israel ltd - moroctocog alfa - powder and solvent for solution for injection - moroctocog alfa 1000 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency)

DIPROFOL 1 % Israel - English - Ministry of Health

diprofol 1 %

taro international ltd, israel - propofol - emulsion for injection or infusion - propofol 10 mg/ml - propofol - propofol - diprofol 1% is a short-acting intravenous general anaesthetic for:• induction and maintenance of general anaesthesia in adults and children > 1 month.• sedation of ventilated patients > 16 years of age in the intensive care unit.• sedation for diagnostic and surgical procedures, alone or in combination with local or regional anaesthesia in adults and children > 1 month..

DIPROFOL 1 % Israel - English - Ministry of Health

diprofol 1 %

taro international ltd, israel - propofol - emulsion for injection or infusion - propofol 10 mg/ml - propofol - propofol - diprofol 1% is a short-acting intravenous general anaesthetic for:• induction and maintenance of general anaesthesia in adults and children > 1 month.• sedation of ventilated patients > 16 years of age in the intensive care unit.• sedation for diagnostic and surgical procedures, alone or in combination with local or regional anaesthesia in adults and children > 1 month.

DIPROFOL 2 % Israel - English - Ministry of Health

diprofol 2 %

taro international ltd, israel - propofol - emulsion for injection or infusion - propofol 20 mg/ml - propofol - propofol - propofol 2% is a short- acting intravenous general anaesthetic for:• induction and maintenance of general anaethesia in adults and children > 3 years.• sedation of ventilated patients >16 years of age in the intensive care unit.• sedation for diagnostic and surgical procedures, alone or in combination with local or regional anaesthesia in adults and children > 3 years.

DOPACIS 90 MBq/ml Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

dopacis 90 mbq/ml solution for injection

cis bio international - fluorodopa (18 f) - solution for injection - 90 mbq/ml - other diagnostic radiopharmaceuticals for tumour detection

Tekcis 2-50 GBq radionuclide generator Ireland - English - HPRA (Health Products Regulatory Authority)

tekcis 2-50 gbq radionuclide generator

cis bio international - sodium pertechnetate (99m tc) - radionuclide generator - 2-50 gigabecquerel(s) - various thyroid diagnostic radiopharmaceuticals; technetium (99mtc) pertechnetate

Dopacis 90 MBq/mL solution for injection Malta - English - Medicines Authority

dopacis 90 mbq/ml solution for injection

cis bio international route nationale 306-saclay, bp 32, 91192, gif-sur-yvette cedex, france - fluorodopa - solution for injection - fluorodopa (18f) 90 mbq/ml - diagnostic radiopharmaceuticals

TYVENSE 20 Milligram Capsules Hard Ireland - English - HPRA (Health Products Regulatory Authority)

tyvense 20 milligram capsules hard

shire pharmaceutical contracts ltd - lisdexamfetamine dimesylate - capsules hard - 20 milligram - phenylethylamine derivatives - centrally acting sympathomimetics - it is indicated as part of a comprehensive treatment programme for attention deficit/hyperactivity disorder (adhd) in children aged 6 years and over when response to previous methylphenidate treatment is considered clinically inadequate